Published 3 February 2009, doi:10.1136/bmj.b232
Cite this as: BMJ 2009;338:b232

Analysis

Relationships with the drug industry: Collaboration to improve care

¹ Schering Plough UK, Welwyn Garden City, Hertfordshire AL7 1TW

The relationship between the drug industry, academia, healthcare professionals, and patients has reached an all time low and few doubt that it is in the interests of all parties to improve it. A recent report from the Royal College of Physicians attempts to define a path towards achieving a more productive relationship. Here we set out five contrasting views on what the ideal relationship between industry and prescribers and patients should be and what steps need to be taken to achieve it (doi:10.1136/bmj.b222, doi:10.1136/bmj.b211, doi:10.1136/bmj.b252, doi:10.1136/bmj.b234)

The first 150 words of the full text of this article appear below.

Healthcare professionals and patients need to have the most up to date information on all the treatment options available to them, including medicines. There is therefore a legitimate place for a responsible relationship between the drug industry and the NHS, prescribers, and patients. This relationship should support the promotion of good medical care, improve health outcomes, and reduce health inequalities. It should include the provision of information to guide valid patient choice.

Doctors, nurses, and pharmacists all receive rigorous training, and patients demand a high degree of medical and pharmacological knowledge from them. Despite this, there are those who would deny healthcare professionals access to the drug industry, which researched and undertook the clinical trials to develop the medicines.

It is paradoxical that some do not consider doctors capable of separating good information from bad. Relations with industry have changed in recent years. The appropriately derided medical conference junket culture . . . [Full text of this article]

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    StumbleUpon    Technorati    What's this?

Relevant Articles

Doctors, patients, and the drug industry

Fiona Godlee
BMJ 2009 338: b463. [Extract] [Full Text]

Relationships with the drug industry: More regulation, greater transparency

Harlan M Krumholz and Joseph S Ross
BMJ 2009 338: b211. [Extract] [Full Text]

Relationships with the drug industry: Build trust based on good science

Scott Gottlieb
BMJ 2009 338: b234. [Extract] [Full Text]

Relationships with the drug industry: Focus on better information

Richard Tiner
BMJ 2009 338: b252. [Extract] [Full Text]

Doctors, patients, and the pharmaceutical industry

Joe Collier
BMJ 2009 338: b443. [Extract] [Full Text]

Related external webpages:

Listen to the doctors and drug industry podcast special, Tessa Richards and Jane Smith interview key players in the debate.

Online poll

Find out more on doc2doc >>